参考文献/References:
[1]Hirsh BJ,Copeland-Halperin RS,Halperin JL. Fibrotic atrial cardiomyopathy,atrial fibrillation,and thromboembolism:mechanistic links and clinical inferences[J]. J Am Coll Cardiol,2015,65(20):2239-2251.
[2]Korantzopoulos P,Letsas KP, Tse G,et al. Inflammation and atrial fibrillation:a comprehensive review[J]. J Arrhythm.2018,34(4):394-401.
[3]Frustaci A,Chimenti C,Bellocci F,et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation[J].Circulation,1997,96(4):1180-1184.
[4]Lazzerini PE,Capecchi PL,Laghi-Pasini F. Systemic inflammation and arrhythmic risk:lessons from rheumatoid arthritis[J]. Eur Heart J,2017,38(22):1717-1727.
[5]Chung M,Martin DO,Sprecher D,et al. C-reactive protein elevation in patients with atrial arrhythmias:inflammatory mechanisms and persistence of atrial fibrillation[J]. Circulation,2001,104(24):2886-2891.
[6]Holbrook J,Lara-Reyna S,Jarosz-Griffiths H,et al. Tumour necrosis factor signalling in health and disease[J].F1000Res,2019,8.pii: F1000 Faculty Rev-111.
[7]Lakin R,Polidovitch N,Yang S,et al. Inhibition of soluble TNFα prevents adverse atrial remodeling and atrial arrhythmia susceptibility induced in mice by endurance exercise[J]. J Mol Cell Cardiol,2019,129:165-173.
[8]Rao F, Xue YM, Wei W,et al. Role of tumour necrosis factor-a in the regulation of T-type calcium channel current in HL-1 cells[J]. Clin Exp Pharmacol Physiol,2016,43(7):706-711.
[9]Stanciu AE,Vatasescu RG,Stanciu MM,et al. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation[J]. Cytokine,2018,103:63-68.
[10]杨海玉,王晓华. 白介素-6在心房颤动疗效及预后评估中的作用[J]. 心血管病学进展,2018,39(5):789-791.
[11]Marcus GM,Smith LM,Ordovas K,et al. Intracardiac and extracardiac markers of inflammation during atrial fibrillation[J]. Heart Rhythm,2010,7(2):149-154.
[12]van Wagoner DR, Chung MK. Inflammation,inflammasome activation,and atrial fibrillation[J]. Circulation.2018,138(20):2243-2246.
[13]Mitrokhin VM, Mladenov MI, Kamkin AG. Effects of interleukin-6 on the bio-electric activity of rat atrial tissue under normal conditions and during gradual stretching[J]. Immunobiology,2015,220(9):1107-1112.
[14]Kondo H,Abe I,Gotoh K,et al. Interleukin 10 treatment ameliorates high-fat diet-induced inflammatory atrial remodeling and fibrillation[J]. Circ Arrhythm Electrophysiol,2018,11(5):e006040.
[15]Li W,Li S,Li X,et al. Interleukin-37 elevation in patients with atrial fibrillation[J]. Clin Cardiol,2017,40(2):66-72.
[16]Hu YF,Chen YJ,Lin YJ,et al. Inflammation and the pathogenesis of atrial fibrillation[J]. Nat Rev Cardiol,2015,12(4):230-243.
[17]陈月,夏云龙. 心房颤动与血清尿酸水平的相关性研究进展[J].心血管病学进展,2018,39(5):792-795.
[18]Andrade J,Khairy P,Dobrev D,et al. The clinical profile and pathophysiology of atrial fibrillation:relationships among clinical features,epidemiology,and mechanisms[J]. Circ Res,2014,114:1453-1468.
[19]Hong KL,Glover BM. The impact of lifestyle intervention on atrial fibrillation[J]. Curr Opin Cardiol,2018,33(1):14-19.
[20]Mart?nez-Gonzalez MA,Toledo E,Arós F,et al. Extravirgin olive oil consumption reduces risk of atrial fibrillation:the PREDIMED(Prevención con Dieta Mediterránea)trial[J]. Circulation,2014,130:18-26.
[21]Rienstra M,Hobbelt AH,Alings M,et al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation:results of the RACE 3 trial[J]. Eur Heart J,2018,39(32):2987-2996.
[22]Kim YR,Nam GB,Han S,et al. Effect of short-term steroid therapy on early recurrence during the blanking period after catheter ablation of atrial fibrillation[J]. Circ Arrhythm Electrophysiol,2015,8(6):1366-1372.
[23]Liu C,Wang J,Yiu D,et al. The efficacy of glucocorticoids for the prevention of atrial fibrillation,or length of intensive care unit or hospital stay after cardiac surgery:a meta-analysis[J]. Cardiovasc Ther,2014,32(3):89-96.
[24]Salih M,Smer A,Charnigo R,et al. Colchicine for prevention of post-cardiac procedure atrial fibrillation:meta-analysis of randomized controlled trials[J]. Int J Cardiol,2017,243:258-262.
[25]An J,Shi F,Liu S,et al. Preoperative statins as modifiers of cardiac and inflammatory outcomes following coronary artery bypass graft surgery:a meta-analysis[J]. Interact Cardiovasc Thorac Surg,2017,25(6):958-965.
[26]Yan P,Dong P,Li Z,et al. Statin therapy decreased the recurrence frequency of atrial fibrillation after electrical cardioversion:a meta-analysis[J]. Med Sci Monit,2014,20:2753-2758.
[27] Korantzopoulos P,Kokkoris S,Kountouris E,et al.Regression of paroxysmal atrial fibrillation associated with thiazolidinedione therapy[J]. Int J Cardiol,2008,125(3):e51-e53.
[28]Liu T,Korantzopoulos P,Shao Q,et al. Mineralocorticoid receptor antagonists and atrial fibrillation:a meta-analysis[J]. Europace,2016,18(5):672-678.
[29]Neefs J,van den Berg NW,Limpens J,et al. Aldosterone pathway blockade to prevent atrial fibrillation:a systematic review and meta-analysis[J]. Int J Cardiol,2017,231:155-161.
相似文献/References:
[1]许少华,张曼,综述,等.晚钠电流与舒张性心力衰竭[J].心血管病学进展,2016,(2):213.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.030]
XU Shaohua,ZHANG Man,ZHANG Jin,et al.Late Sodium Current and Diastolic Heart Failure[J].Advances in Cardiovascular Diseases,2016,(1):213.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.030]
[2]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(1):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[3]朱晓龙侯阳.细胞焦亡的分子机制其在心血管病变中的研究进展[J].心血管病学进展,2020,(8):847.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.016]
ZHU Xiaolong,HOU Yang.Molecular Mechanism of yroptosis and Its Research Progress in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(1):847.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.016]
[4]赵琳 孟旭 周宪梁.正常高值血压人群血清炎性标志物研究进展[J].心血管病学进展,2020,(11):1116.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
ZHAO Lin,MENG Xu,ZHOU Xianliang.Serum Inflammatory Markers in Population with High Normal Blood Pressure[J].Advances in Cardiovascular Diseases,2020,(1):1116.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[5]张菲菲 周子皓 王芳.白介素在血管钙化作用机制中的研究进展[J].心血管病学进展,2021,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.018]
HANG Feifei,ZHOU Zihao,WANG Fang?/html>.Research Progress of Interleukin in the Mechanism?f Vascular Calcification[J].Advances in Cardiovascular Diseases,2021,(1):364.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.018]
[6]魏天天?王学超?吴海波?杜荣品.心力衰竭生物标志物的研究进展[J].心血管病学进展,2021,(7):610.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.009]
WEI Tiantian,WANG Xuechao,WU Haibo,et al.Biomarkers of Heart Failure[J].Advances in Cardiovascular Diseases,2021,(1):610.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.009]
[7]王兰 叶玉兰 宁明安 张迪 尚粉青.血清PCSK9水平与PCI后冠状动脉病变再进展的关系研究[J].心血管病学进展,2022,(7):667.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
WANG Lan,YE Yulan,NING Mingan,et al.Correlation Analysis Between Serum PCSK9 Level and Coronary Artery Pathological ?Progression After PCI[J].Advances in Cardiovascular Diseases,2022,(1):667.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[8]王朝阳 赵丽娜 田师鹏 陈淑霞 谷剑.炎症治疗在动脉粥样硬化中的研究进展[J].心血管病学进展,2023,(6):519.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.009]
WANG Zhaoyang,ZHAO Lina,TIAN Shipeng,et al.Advances in the Treatment of Inflammation in Atherosclerosis[J].Advances in Cardiovascular Diseases,2023,(1):519.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.009]
[9]王学文?柯元甲?赵庆彦.自主神经调控免疫重构与房颤的发生[J].心血管病学进展,2023,(7):645.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.016]
WANG Xuewen,KE Yuanjia,ZHAO Qingyan.Autonomic Nerve Regulates Immune Remodeling and The Occurrence of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2023,(1):645.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.016]
[10]牟秦娇 张玥 王楠.无导线起搏器在特殊人群中植入的研究进展[J].心血管病学进展,2023,(8):694.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.006]
MOU QinjiaoZHANG YueWANG Nan.Analysis of Implantation of Leadless Pacemakers in Special Populations[J].Advances in Cardiovascular Diseases,2023,(1):694.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.006]